Literature DB >> 18716746

Current trends in the management of beta thalassemia.

A P Dubey1, A Parakh, S Dublish.   

Abstract

The management of Beta Thalassemia, the commonest form of hemolytic anemia in children, has changed significantly in the last few years. With the availability of better transfusion regimen, iron chelation therapy, proper management of complications and good supportive care, it is now possible for a thalassemic child to have a near normal life span with a good quality of life.

Entities:  

Mesh：

Year:  2008        PMID： 18716746     DOI： 10.1007/s12098-008-0140-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  19 in total

1.  Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload.

Authors:  R Chatterjee; M Katz
Journal:  Clin Endocrinol (Oxf)       Date:  2000-07       Impact factor: 3.478

2.  Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.

Authors:  Lisa J Anderson; Beatrix Wonke; Emma Prescott; Sally Holden; J Malcolm Walker; Dudley J Pennell
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

3.  Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Authors:  Caterina Borgna-Pignatti; Maria Domenica Cappellini; Piero De Stefano; Giovanni Carlo Del Vecchio; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Maria Antonietta Romeo; Huaqing Zhao; Avital Cnaan
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

4.  Fertility in female patients with thalassemia.

Authors:  N Skordis; S Christou; M Koliou; N Pavlides; M Angastiniotis
Journal:  J Pediatr Endocrinol Metab       Date:  1998       Impact factor: 1.634

5.  Combined therapy with deferiprone and desferrioxamine in thalassemia major.

Authors:  Raffaella Origa; Patrizio Bina; Annalisa Agus; Gabriella Crobu; Elisabetta Defraia; Carlo Dessì; GiovanBattista Leoni; Pier Paolo Muroni; Renzo Galanello
Journal:  Haematologica       Date:  2005-10       Impact factor: 9.941

6.  Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.

Authors:  Vassilis Ladis; George Chouliaras; Helen Berdousi; Emmanuel Kanavakis; Christos Kattamis
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

7.  A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Authors:  Maria Domenica Cappellini; Alan Cohen; Antonio Piga; Mohamed Bejaoui; Silverio Perrotta; Leyla Agaoglu; Yesim Aydinok; Antonis Kattamis; Yurdanur Kilinc; John Porter; Marcello Capra; Renzo Galanello; Slaheddine Fattoum; Guillermo Drelichman; Carmelo Magnano; Monica Verissimo; Miranda Athanassiou-Metaxa; Patricia Giardina; Alexandra Kourakli-Symeonidis; Gritta Janka-Schaub; Thomas Coates; Christiane Vermylen; Nancy Olivieri; Isabelle Thuret; Herbert Opitz; Catherine Ressayre-Djaffer; Peter Marks; Daniele Alberti
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 8.  Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.

Authors:  D J Roberts; D Rees; J Howard; C Hyde; P Alderson; S Brunskill
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

9.  Factors determining glucose tolerance in patients with thalassemia major.

Authors:  K Dmochowski; D T Finegood; W Francombe; B Tyler; B Zinman
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

10.  Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).

Authors:  Vincenzo De Sanctis; Androulla Eleftheriou; Cristina Malaventura
Journal:  Pediatr Endocrinol Rev       Date:  2004-12
View more
  12 in total

1.  Detection of myocardial iron overload by two-dimensional speckle tracking in patients with beta-thalassaemia major: a combined echocardiographic and T2* segmental CMR study.

Authors:  Fausto Pizzino; Antonella Meloni; Anna Terrizzi; Tommaso Casini; Anna Spasiano; Carlo Cosmi; Massimo Allò; Concetta Zito; Scipione Carerj; Giovanni Donato Aquaro; Gianluca Di Bella; Alessia Pepe
Journal:  Int J Cardiovasc Imaging       Date:  2017-08-02       Impact factor: 2.357

2.  Factors affecting health-related quality of life in Thai children with thalassemia.

Authors:  Montarat Thavorncharoensap; Kitti Torcharus; Issarang Nuchprayoon; Arthorn Riewpaiboon; Kaemthong Indaratna; Bang-On Ubol
Journal:  BMC Blood Disord       Date:  2010-01-21

3.  Psychometric properties of the Specific Thalassemia Quality of Life Instrument for adults.

Authors:  Georgios N Lyrakos; Demetra Vini; Helen Aslani; Marouso Drosou-Servou
Journal:  Patient Prefer Adherence       Date:  2012-07-02       Impact factor: 2.711

4.  Anxiety and depression affects life and sleep quality in adults with beta-thalassemia.

Authors:  Bashir Hajibeigi; Azita Azarkeyvan; Seyed Moayed Alavian; Maryam Moghani Lankarani; Shervin Assari
Journal:  Indian J Hematol Blood Transfus       Date:  2009-07-05       Impact factor: 0.900

5.  Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia.

Authors:  Azita Azarkeivan; Bashir Hajibeigi; Seyed Moayed Alavian; Maryam Moghani Lankarani; Shervin Assari
Journal:  J Res Med Sci       Date:  2009-11       Impact factor: 1.852

Review 6.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

7.  Thalassemia Major in Adults: Short Stature, Hyperpigmentation, Inadequate Chelation, and Transfusion-Transmitted Infections are Key Features.

Authors:  Anupam Prakash; Ramesh Aggarwal
Journal:  N Am J Med Sci       Date:  2012-03

8.  Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran.

Authors:  Sezaneh Haghpanah; Masoomeh Esmaeilzadeh; Naser Honar; Fatemeh Hassani; Javad Dehbozorgian; Narges Rezaei; Maryam Abdollahi; Marzieh Bardestani; Sanaz Safaei; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2015-07-01       Impact factor: 0.611

9.  Comprehensive patient care improves quality of life in transfusion dependent patients with β-thalassemia.

Authors:  Salah S Ali; Ahmad M Tarawah; Zakaria M Al-Hawsawi; Mohammed A Zolaly; Waheed Turkustani
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

10.  Prevalence of Transfusion Transmitted Infections and the Quality of Life in β-thalassemia Major Patients.

Authors:  May Al-Moshary; Eman Al-Mussaed; Adnan Khan
Journal:  Cureus       Date:  2019-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.